Note: Ingredients listed on restricted chemical lists
EC/CAS
69-65-8
Name of the chemical
D-mannitol C6H14O6
Concentration
N/A
EC/CAS
9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
N/A
EC/CAS
200-711-8
Name of the chemical
D-mannitol C6H14O6
Concentration
N/A
General Information
Revision date
2007-01-05
Product name
Trelstar (R); Decapeptryl (R)
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Inc
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Appearance: White to slightly yellow (lyophilised) powder
Signal word
WARNING
Hazard statements
May cause reproductive system effects
Additional information
Short Term: Toxicity following ingestion is not expected. However, ingestion should be avoided. Long Term: Adverse reproductive effects seen in repeat-dose animal studies are consistent with the pharmacologic action of this drug and are expected to be relevant to humans. Known Clinical Effects: Adverse effects most commonly reported in clinical use include hot flushes, leg pain, nausea, diarrhea, insomnia, and headache. Can produce impotence and other sexual disturbances in men. EU Indication of danger: Toxic to reproduction: Category 1 EU Hazard Symbols: EU Risk Phrases: R60 - May impair fertility. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
